Genetic factors determine the contribution of leukotrienes to acute inflammatory responses

Journal of Immunology

Volumn 164, Issue 9, 2000, Pages 4899-4907

  Goulet, Jennifer L ^a,b   Byrum, Robert S ^a   Key, Mikelle ^a   Nguyen, MyTrang ^a   Wagoner, Victoria A ^a   Koller, Beverly H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; LEUKOTRIENE; PROSTANOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; GENETIC ANALYSIS; HEREDITY; IMMUNE RESPONSE; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0034192098     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.9.4899     Document Type: Article

References (40)

1. Needleman, P., J. Turk, B. A. Jakschik, A. R. Morrison, and J. B. Lefkowith. 1986. Arachidonic acid metabolism. Annu. Rev. Biochem. 55:69.
2. Williams, K. I., and G. A. Higgs. 1988. Eicosanoids and inflammation. J. Pathol. 156:101.
3. Goetzl, E. J., A. Songzhu, and W. L. Smith. 1995. Specificity of expression and effects of eicosanoid mediators in normal physiology an human diseases. FASEB J. 9:1051.
4. Smith, W. L. 1992. Prostanoid biosynthesis and mechanisms of action, Am. J. Physiol. 263:F181.
5. 2. Biochim. Biophys. Acta. 117:217.
6. 2 enzymes: regulation and physiological role. Biochem. Pharmacol. 48:1.
7. 2 to the nuclear fraction upon macrophage activation. Biochem. Biophys. Res. Commun. 196:147.
8. Woods, J. W., J. F. Evans, D. Ethier, S. Scott, P. J. Vickers, L. Hearn, J. A. Heibein, S. Charleson, and I. I. Singer. 1993. 5-Lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med. 178:1935.
9. Ford-Hutchinson, A. W., M. Gresser, and R. N. Young. 1994. 5-Lipoxygenase. Annu. Rev. Biochem. 63:383.
10. Woods, J. W., M. J. Coffey, T. G. Brock, I. I. Singer, and M. Peters-Golden. 1995. 5-Lipoxygenase is located in the euchromatin of the nucleus in the resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J. Clin. Invest. 95:2035.
11. Samuelsson, B. 1983. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220:568.
12. Henderson, W. R., Jr. 1994. The role of leukotrienes in inflammation. Ann. Intern. Med. 121:684.
13. Lewis, R. A., K. F. Austen, and R. J. Soberman. 1990. Leukotrienes and other products of the 5-lipoxygenase pathway, biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 323:645.
14. Goetzl, E. J., and W. C. Pickett. 1980. The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs). J. Immunol. 125: 1789.
15. 4: a potential mediator of inflammation. J. Pharm. Pharmacol. 32:517.
16. 4: implications for the regulation of inflammatory responses. Br. J. Pharmacol. 110:423.
17. Dahlen, S.-E., J. Bjork, P. Hedqvist, K.-E. Arfors, S. Hammarstrom, J.-A. Lindgren, and B. Samuelsson. 1981. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc. Natl. Acad. Sci. USA 78:3887.
18. 4 that mediates chemotaxis. Nature 387:620.
19. Coleman, R. A., R. M. Eglen, R. L. Jones, S. Narumiya, T. Shimizu, W. L. Smith, S. E. Dahlen, J. M. Drazen, P. J. Gardiner, W. T. Jackson, et al. 1995. Prostanoid and leukotriene receptors: a progress report from the 1UPHAR working parties on classification and nomenclature. Adv. Prostaglandin Thromboxane Leukotriene Res. 23:283.
20. Metters, K. M. 1995. Leukotriene receptors. J. Lipid Media. Cell Signal. 12:413.
21. 1 receptor. Nature 399:789.
22. Chen, X.-S., J. R. Sheller, E. N. Johnson, and C. D. Funk. 1994. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 372: 179.
23. Goulet, J. L., J. N. Snouwaert, A. M. Latour, T. M. Coffman, and B. H. Koller. 1994. Altered inflammatory responses in leukotriene-deficient mice. Proc. Natl. Acad. Sci. USA 91:12852.
24. Byrum, R. S., J. L. Goulet, R. J. Griffiths, and B. H. Koller. 1997. Role of the 5-lipoxygenase activating protein (FLAP) in murine acute inflammatory responses. J. Exp. Med. 185:1065.
25. Goulet, J. L., R. C. Griffiths, P. Ruiz, R. F. Spurney, D. S. Pisetsky, B. H. Koller, and T. M. Coffman. 1999. Deficiency of 5-lipoxygenase abolishes sex-related survival differences in MRL-lpr/lpr mice. J. Immunol. 163:359.
26. De Sanctis, G. T., and J. M. Drazen. 1997. Genetics of native airway responsiveness in mice. Am. J. Respir. Crit. Care Med. 156:S82.
27. 2 gene in inbred mouse strains. J. Biol. Chem. 270:22378.
28. Min-induced intestinal neoplasia. Cell 81:957.
29. Jancso-Gabor, A., J. Szolcsanyi, and N. Jancso. 1967. A simple method for measuring the amount of azovan blue exuded into the skin in response to an inflammatory stimulus. J. Pharm. Pharmacol. 19:486.
30. Rao, T. S., J. L. Currie, A. F. Shaffer, and P. C. Isakson. 1994. In vivo characterization of zymosan-induced mouse peritoneal inflammation. J. Pharmacol. Exp. Ther. 269:917.
31. Hooper, M., K. Hardy, A. Handyside, S. Hunter, and M. Monk. 1987. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 326:292.
32. Young, J. M., D. A. Spires, C. J. Bedord, B. Wagner, S. J. Ballaron, and L. M. De Young. 1984. The mouse ear inflammatory response to topical arachidonic acid. J. Invest. Dermatol. 82:367.
33. Carlson, R. P., L. O'Neill-Davis, J. Chang, and A. J. Lewis. 1985. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents. Agents Actions 17:197.
34. Opas, E. E., R. J. Bonney, and J. L. Humes. 1985. Prostaglandin and leukotriene synthesis in mouse ears inflamed by arachidonic acid. J. Invest. Dermatol. 84: 253.
35. Chang, J., R. P. Carlson, L. O'Neill-Davis, B. Lamb, R. N. Sharma, and A. J. Lewis. 1986. Correlation between mouse skin inflammation induced by arachidonic acid and eicosanoid synthesis. Inflammation 10:205.
36. Langenbach, R., S. G. Morham, H. F. Tiano, C. D. Loftin, B. I. Ghanayem, P. C. Chulada, J. F. Mahler, C. A. Lee, E. H. Goulding, K. D. Kluckman, et al. 1995. Prostaglandin synthase I gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83:483.
37. Claesson, H.-E., and S.-E. Dahlen. 1999 Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs. J. Intern. Med. 245:205.
38. Sanak, M., and A. P. Sampson, 1999. Biosynthesis of cysteinyl-leucotrienes in aspirin-intolerant asthma. Clin. Exp. Allergy 29:306.
39. 4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 350:1599.
40. 4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J. Clin. Invest. 101:834